Hematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation, HomologousHematopoietic Stem CellsGraft vs Host DiseaseTransplantation, AutologousStem Cell TransplantationTransplantation ConditioningBone MarrowBone Marrow CellsHematologic NeoplasmsGraft SurvivalTransplantation ChimeraWhole-Body IrradiationPeripheral Blood Stem Cell TransplantationStem CellsTissue DonorsLiver TransplantationLeukemiaBusulfanHistocompatibility TestingTreatment OutcomeHistocompatibilityHematopoiesisAnemia, AplasticRecurrenceCord Blood Stem Cell TransplantationRetrospective StudiesKidney TransplantationCombined Modality TherapyImmunosuppressive AgentsTransplantation, IsogeneicRemission InductionGraft vs Leukemia EffectHematopoietic Stem Cell MobilizationCyclophosphamideAntigens, CD34Leukemia, Myeloid, AcuteHepatic Veno-Occlusive DiseaseTime FactorsMyeloablative AgonistsMice, Inbred C57BLBone and BonesChimerismTransplantation ImmunologyHLA AntigensCell DifferentiationHematologic DiseasesMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival AnalysisSevere Combined ImmunodeficiencyBone Marrow PurgingMultiple MyelomaSurvival RateGraft vs Tumor EffectGraft RejectionLymphocyte TransfusionColony-Forming Units AssayCell TransplantationLymphocyte DepletionDisease-Free SurvivalMesenchymal Stem Cell TransplantationFlow CytometryAcute DiseaseMelphalanImmunosuppressionT-LymphocytesCell LineageHeart TransplantationLymphoma, Non-HodgkinBone Marrow DiseasesLeukemia, MyeloidFollow-Up StudiesGranulocyte Colony-Stimulating FactorCytomegalovirus InfectionsRadiation ChimeraSiblingsAntineoplastic Combined Chemotherapy ProtocolsVidarabineAntilymphocyte SerumUnrelated DonorsLung TransplantationOrgan TransplantationCells, CulturedSalvage TherapyCyclosporineFetal BloodStem Cell NicheCell SeparationCytarabineOpportunistic InfectionsEmbryonic Stem CellsPrognosisTransplantationAdult Stem CellsLeukocyte TransfusionImmunocompromised HostInfection